We sat down with Graeme Johnston, rheumatoid arthritis (RA) patient advocate and Board Member, Patient Focused Medicines Development (PFMD) to talk about his active role in the RA community and his experiences working with pharma companies to advocate for patients with RA during the 15 years he has been living with the condition.
Graeme describes his desire for greater understanding in the pharma industry of the day-to-day lives of patients with RA and the large impact that small changes can make, such as greater consideration of the form prescribed treatments can take.
